Literature DB >> 9680127

Active domains of human papillomavirus type 11 E1 protein for origin replication.

Y Sun1, H Han, D J McCance.   

Abstract

Viral proteins E1 and E2 are essential for transient human papillomavirus (HPV) DNA replication. E1 is a multifunctional protein which can bind DNA and complex with E2, has ATPase and helicase activities, and interacts with DNA polymerase alpha-primase. E2 is a transactivator-repressor protein, playing an important role in replication and transcriptional regulation. A series of deletion mutants of HPV-11 E1 were constructed and tested in functional assays to define those domains of HPV-11 E1 which are important for binding to the origin DNA and E2. The domain of HPV-11 E1 involved in binding to the origin was located between aa 186 and 649, and that for binding to E2 was between aa 346 and 649. Since E1 binds to the origin more efficiently in the presence of E2, we also mapped the DNA binding domain of E1 in the presence of E2, and found that when binding was enhanced, the region of E1 involved in binding was similar to that observed with E1 alone. The same deletion mutation constructs of E1 were subcloned into an expression vector for use in transient replication assays to study the effect of the deletions on the replication of the origin DNA in vivo and the data suggest that the C-terminal domain contains important functions for replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680127     DOI: 10.1099/0022-1317-79-7-1651

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Authors:  Paramananda Saikia; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Artificial Recruitment of UAF1-USP Complexes by a PHLPP1-E1 Chimeric Helicase Enhances Human Papillomavirus DNA Replication.

Authors:  David Gagnon; Michaël Lehoux; Jacques Archambault
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

3.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 4.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

Review 5.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

6.  Papillomavirus E1 protein binds to and stimulates human topoisomerase I.

Authors:  Randolph V Clower; John C Fisk; Thomas Melendy
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.

Authors:  Amélie Fradet-Turcotte; Fanny Bergeron-Labrecque; Cary A Moody; Michaël Lehoux; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

8.  Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin.

Authors:  S Titolo; A Pelletier; A M Pulichino; K Brault; E Wardrop; P W White; M G Cordingley; J Archambault
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin.

Authors:  S Titolo; A Pelletier; F Sauvé; K Brault; E Wardrop; P W White; A Amin; M G Cordingley; J Archambault
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

10.  Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.

Authors:  Amélie Fradet-Turcotte; Karine Brault; Steve Titolo; Peter M Howley; Jacques Archambault
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.